STOCK TITAN

Ufp Technologies Stock Price, News & Analysis

UFPT Nasdaq

Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.

UFP Technologies, Inc. (UFPT) delivers innovative custom-engineered solutions for medical device manufacturers and industrial partners through advanced material science and precision manufacturing. This news hub provides investors and industry professionals with direct access to UFPT's official announcements and strategic developments.

Track all corporate communications including quarterly earnings, product innovation launches, and strategic partnerships. Our curated collection features regulatory filings, manufacturing process advancements, and market expansion updates essential for understanding UFPT's position in specialty packaging and component manufacturing.

Key updates cover medical sector innovations, new material applications, and OEM collaboration milestones. Stay informed about UFPT's patented technologies and engineering capabilities that drive solutions for minimally invasive surgery, implant packaging, and aerospace components.

Bookmark this page for real-time updates on UFPT's operational developments and industry leadership. Regularly refreshed content ensures you maintain current awareness of this critical supply chain partner's evolving market role.

News
Rhea-AI Summary

UFP Technologies, Inc. (Nasdaq: UFPT) reported a net income of $15.9 million for 2021, up from $13.4 million in 2020, resulting in a 18% increase in earnings per diluted share. Sales rose by 15% to $206.3 million. However, Q4 saw a drop in net income to $3.2 million, down from $4.2 million in 2020, despite a 24.8% increase in sales. The company faced challenges with rising raw material costs and supply chain issues, but expects improvement as price increases are implemented. UFP is also optimistic about future growth following recent acquisitions and the establishment of operations in Tijuana, Mexico.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.09%
Tags
none
-
News
Rhea-AI Summary

UFP Technologies, Inc. (Nasdaq: UFPT) announced the acquisition of DAS Medical, Inc., a contract manufacturer specializing in single-use surgical equipment. This strategic acquisition enhances UFP's MedTech portfolio, providing complementary manufacturing capabilities in thin film converting and expanding low-cost production options in the Dominican Republic and Mexico. UFP aims to leverage DAS’s expertise to offer a full suite of services for flexible medical devices, fostering growth and value creation for their shared customer base.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.54%
Tags
-
Rhea-AI Summary

UFP Technologies, Inc. (Nasdaq: UFPT) reported a notable increase in Q3 2021 financial performance. Net income reached $3.8 million ($0.50 per share), up from $3.0 million ($0.40 per share) in Q3 2020. Sales surged 17.1% to $50.7 million year-over-year, with sales to the medical market climbing 20.5%. Year-to-date net income stood at $12.7 million, a 38% increase from 2020. However, gross margin decreased to 23.7% from 24.3% in Q3 2020. The CEO highlighted challenges including labor shortages and supply chain issues but expressed optimism about future growth and ongoing acquisitions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.62%
Tags
none
Rhea-AI Summary

AliMed, Inc. has appointed Adam S. Epstein as the new Chief Executive Officer, effective immediately. Epstein, previously the Chief Commercial Officer, aims to strengthen the company's operations and product portfolio serving leading healthcare providers. AliMed, known for its innovative medical supplies, has focused on growth through partnerships with national GPOs and IDNs while enhancing product development. Under Epstein's leadership, AliMed seeks to improve patient outcomes through its comprehensive healthcare offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.91%
Tags
none
-
Rhea-AI Summary

UFP Technologies, Inc. (Nasdaq: UFPT) has acquired Contech Medical, Inc., a leader in class III medical device packaging, primarily for catheters and guidewires, with annual sales of approximately $18 million. This acquisition is seen as a strategic fit, allowing UFP to enhance its medical offerings and strengthen customer relationships, as about 70% of Contech’s customers are already UFP clients. The deal is expected to be immediately accretive to earnings and capitalize on the strong growth potential of the medical market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
-
Rhea-AI Summary

On September 21, 2021, UFP Technologies, Inc. (Nasdaq: UFPT) announced that CEO R. Jeffrey Bailly and CFO Ron Lataille will present at the Sidoti Fall Virtual Investor Conference scheduled for September 22-23, 2021. The live presentation will start at 10:00 A.M. ET on September 22 and can be accessed here. Additionally, one-on-one meetings with investors will be hosted by the company on the same day. Registration is free and open to all interested parties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
conferences
Rhea-AI Summary

UFP Technologies (Nasdaq: UFPT) announced that CEO Jeff Bailly and CFO Ron Lataille will present at the virtual Midwest IDEAS Investor Conference on August 26, 2021. The company specializes in designing and manufacturing components and packaging for the medical sector, utilizing advanced materials like foams and plastics. UFP also serves diverse markets, including aerospace and automotive. This conference aims to connect quality companies with investment professionals, fostering regional investment communities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.32%
Tags
conferences
-
Rhea-AI Summary

UFP Technologies, Inc. (Nasdaq: UFPT) reported a strong second quarter for 2021, achieving net income of $4.7 million ($0.62 per diluted share), up from $2.3 million ($0.31 per diluted share) in Q2 2020. Sales reached $50.7 million, an 18.8% increase from $42.6 million last year. Year-to-date, net income was $8.9 million, compared to $6.2 million the previous year. Gross margins improved to 26.5%. While challenges in raw material availability and labor shortages persist, the company remains optimistic about growth opportunities and strategic initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.16%
Tags
none
-
Rhea-AI Summary

UFP Technologies (Nasdaq: UFPT), a leading designer and manufacturer for the medical market, will participate in the virtual East Coast IDEAS Investor Conference on June 16, 2021. CEO Jeff Bailly and CFO Ron Lataille will present and conduct one-on-one investor meetings. Interested investors can contact Jeff Elliott at Three Part Advisors for participation details. UFP Technologies specializes in creating components using specialized foams and materials, serving various sectors like aerospace, automotive, and industrial markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.21%
Tags
conferences
Rhea-AI Summary

UFP Technologies (Nasdaq: UFPT) reported Q1 2021 net income of $4.2 million ($0.55/share), up from $3.9 million ($0.52/share) in Q1 2020. Sales rose 0.7% to $48.6 million, with a notable performance in Aerospace & Defense and Consumer markets, growing 68% and 62%, respectively. Medical sales, however, fell by 11.5%. Gross profit margin decreased to 25.9%, while SG&A expenses dropped to 15.0%. The company is optimistic about recovery as elective procedures resume and is focused on strategic initiatives for growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
none

FAQ

What is the current stock price of Ufp Technologies (UFPT)?

The current stock price of Ufp Technologies (UFPT) is $252.36 as of July 1, 2025.

What is the market cap of Ufp Technologies (UFPT)?

The market cap of Ufp Technologies (UFPT) is approximately 1.9B.
Ufp Technologies

Nasdaq:UFPT

UFPT Rankings

UFPT Stock Data

1.86B
7.42M
5.72%
104.58%
13.37%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NEWBURYPORT